A detailed history of Cutter Capital Management, LP transactions in Arcellx, Inc. stock. As of the latest transaction made, Cutter Capital Management, LP holds 187,000 shares of ACLX stock, worth $18.8 Million. This represents 3.12% of its overall portfolio holdings.

Number of Shares
187,000
Previous 107,000 74.77%
Holding current value
$18.8 Million
Previous $7.44 Billion 38.68%
% of portfolio
3.12%
Previous 2.85%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$49.74 - $66.98 $3.98 Million - $5.36 Million
80,000 Added 74.77%
187,000 $10.3 Billion
Q1 2024

May 15, 2024

BUY
$51.85 - $73.49 $5.55 Million - $7.86 Million
107,000 New
107,000 $7.44 Billion

Others Institutions Holding ACLX

About Arcellx, Inc.


  • Ticker ACLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,819,200
  • Market Cap $4.4B
  • Description
  • Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...
More about ACLX
Track This Portfolio

Track Cutter Capital Management, LP Portfolio

Follow Cutter Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutter Capital Management, LP with notifications on news.